Abstract
Despite the advances in surface bioconjugation of synthetic nanoparticles for targeted drug delivery, simple biological functionalization is still insufficient to replicate complex intercellular interactions naturally. Therefore, these foreign nanoparticles are inevitably exposed to the immune system, which results in phagocytosis by the reticuloendothelial system and thus, loss of their biological significance. Immunocyte membranes play a key role in intercellular interactions, and can protect foreign nanomaterials as a natural barrier. Therefore, biomimetic nanotechnology based on cell membranes has developed rapidly in recent years. This paper summarizes the development of immunocyte membrane-coated nanoparticles in the immunotherapy of tumors. We will introduce several immunocyte membrane-coated nanocarriers and review the challenges to their large-scale preparation and application.
Original language | English (US) |
---|---|
Article number | 77 |
Pages (from-to) | 1-17 |
Number of pages | 17 |
Journal | Cancers |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2021 |
Keywords
- Biomimicry
- Cancer immunotherapy
- Dendritic cell
- Immunocyte membrane-coated nanoparticles
- Macrophage
- Natural killer
- T-cell
ASJC Scopus subject areas
- Oncology
- Cancer Research